| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Diclofenac | FAERS: 38 | US FAERS | |
| 2 | Arthrotec | FAERS: 15 | US FAERS | |
| 3 | Isotretinoin | FAERS: 8 | US FAERS | |
| 4 | Ibuprofen | FAERS: 5 | US FAERS | |
| 5 | Olmesartan Medoxomil | FAERS: 4 | US FAERS | |
| 6 | Indomethacin | FAERS: 3 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 7 | Dimethyl Fumarate | FAERS: 2 | US FAERS | |
| 8 | Norgestrel | FAERS: 2 | US FAERS | |
| 9 | Sorafenib | FAERS: 2 | US FAERS | |
| 10 | fesoterodine | FAERS: 2 | US FAERS | |
| 11 | olaparib | FAERS: 2 | US FAERS | |
| 12 | Aspirin | FAERS: 1 | US FAERS | |
| 13 | Benicar hct | FAERS: 1 | US FAERS | |
| 14 | Dabigatran | FAERS: 1 | US FAERS | |
| 15 | Diclofenac | FAERS: 1 | US FAERS | |
| 16 | Ganciclovir | FAERS: 1 | US FAERS | |
| 17 | Imatinib Mesylate | FAERS: 1 | US FAERS | |
| 18 | Lenalidomide | FAERS: 1 | US FAERS | |
| 19 | Letrozole | FAERS: 1 | US FAERS | |
| 20 | Meropenem | FAERS: 1 | US FAERS | |
| 21 | N-(3-amino-1-(cyclobutylmethyl)-2,3-dioxopropyl)-3-(2-((((1,1-dimethylethyl)amino)carbonyl)amino)-3,3-dimethyl-1-oxobutyl)-6,6-dimethyl-3-azabicyclo(3.1.0)hexan-2-carboxamide | FAERS: 1 | US FAERS | |
| 22 | Octreotide | FAERS: 1 | US FAERS | |
| 23 | Paclitaxel | FAERS: 1 | US FAERS | |
| 24 | Tacrolimus | FAERS: 1 | US FAERS | |
| 25 | Tiotropium Bromide | FAERS: 1 | US FAERS | |
| 26 | Vancomycin | FAERS: 1 | US FAERS | |
| 27 | Zoledronic Acid | FAERS: 1 | US FAERS | |
| 28 | apixaban | FAERS: 1 | US FAERS | |
| 29 | ixazomib | FAERS: 1 | US FAERS | |
| 30 | macitentan | FAERS: 1 | US FAERS | |
| 31 | teriflunomide | FAERS: 1 | US FAERS |
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120241
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.